Oxidative Stress in Fibromyalgia: From Pathology to Treatment
Chanika Assavarittirong, Włodzimierz Samborski, Bogna Grygiel‐Górniak · Oxidative Medicine and Cellular Longevity · 2022
Fibromyalgia (FM) is characterized by chronic widespread musculoskeletal pain associated with sleep problems, fatigue, depression, and anxiety. The persistence of pain, impairment of cognitive function, and negative impact on the psychological state have caused a detrimental effect on the patients' quality of life. However, to date, the treatment and mechanisms of this disease are yet to be established. Oxidative stress might play a critical role in FM pathophysiology. Increased levels of prooxidative factors such as nitric oxide, lipid peroxidation, and mitophagy can cause pain sensitization in fibromyalgia. Numerous studies have supported the hypothesis of beneficial antioxidative effects in FM. Due to the lack of effective therapy for fibromyalgia, many treatments are sought to reduce pain and fatigue and improve patients' quality of life. This manuscript discusses the impact of various antioxidative procedures that can diminish fibromyalgia symptoms, such as hyperbaric oxygen therapy, modification of dietary habits, and physical activity.
Cited by 88 works. doi:10.1155/2022/1582432 Open-access PDF
Authors
References
- The american college of rheumatology 1990 criteria for the classification of fibromyalgia
- Measuring Health-Related Quality of Life
- [42] Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal
- The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity
- Autophagy in cell death: an innocent convict?
- Lipid peroxidation and antioxidants as biomarkers of tissue damage
- Basic Neurochemistry: Molecular, Cellular, and Medical Aspects
- Elevated cerebrospinal fluid levels of substance p in patients with the fibromyalgia syndrome
- The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties
- Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome.